Gateshead, United Kingdom

Christopher Brown

This inventor holds 23 USPTO granted patents and 9 published patent applications, primarily in Psychedelic Pharmaceuticals. Top assignees: Compass Pathfinder Limited, Compass Pathways Limited. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Brown. Retrieved from https://idiyas.com/inventor/christopher-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 78.3

Average Co-Inventor Count = 7.1

ph-index = 8

Forward Citations = 294(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Areas of Expertise:
Psilocybin
Anxiety Disorders
Headache Disorders
Eating Disorders
Polymorphic Forms
Chronic Pain
Reducing Inflammation
Formulations
Neurocognitive Disorders
23 patents (USPTO):Explore Patents

Title: Christopher Brown - Innovator in Psilocybin Production

Introduction

Christopher Brown, an accomplished inventor based in Gateshead, GB, holds 13 patents to his name. His groundbreaking work focuses on the production and therapeutic application of psilocybin, which is gaining recognition in the field of medicine.

Latest Patents

Among his latest patents, one highlights the "Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use." This invention pertains to the large-scale production of psilocybin, specifically emphasizing the method of obtaining high purity crystalline psilocybin, particularly in the form of Polymorph A. Additionally, Brown has developed a method for treating various disorders through psilocybin, which includes anxiety disorders, headache disorders, and eating disorders. The disclosed methods provide a therapeutically effective dose to treat subjects in need, showcasing a significant advancement in therapeutic interventions.

Career Highlights

Throughout his career, Christopher Brown has been associated with pioneering companies in the field, including Compass Pathfinder Limited and Compass Pathways Limited. His contributions have played a vital role in the advancement of medical therapies utilizing psilocybin, marking him as a leading figure in pharmaceutical innovation.

Collaborations

Brown has collaborated with notable individuals in his field, including Derek John Londesbrough and Julian Scott Northen. Their combined expertise has fostered an environment of innovation that pushes the boundaries of current research and development in psilocybin applications.

Conclusion

Christopher Brown's commitment to enhancing medical treatments through his patented innovations in psilocybin production is commendable. His work not only demonstrates his prowess as an inventor but also his dedication to improving mental health treatments, thereby contributing significantly to the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…